Select Biosciences Ltd

News Headlines

Bruker Daltonics Announces Opening of maXis™ U.S. Demonstration Facility
06 March 2009
Company announces several maXis installations in top-tier U.S. life-science research laboratories prior to Pittcon.

Burzynski Research Institute Partners with Premier Research to Manage Phase III Clinical Study
04 February 2009
Study moves forward to bring antineoplastons therapy to market for treatment of children with newly-diagnosed diffuse intrinsic brainstem glioma.

Sigma-Aldrich and CPC Scientific Signs Distribution Agreement for Custom Peptide Libraries
30 January 2009
CPC Scientific will offer Sigma-Aldrich's PEPscreen® custom peptide libraries to life science researchers across North America.

GeneBio and Utrecht University Announce Collaborative Partnership Around Phenyx
23 January 2009
University’s Heck Laboratory will utilize GeneBio’s Phenyx software platform in order to get optimized scorings for its Lys-N protein digestion workflow.

Protelica Awarded Phase II SBIR Grant by the National Science Foundation
20 January 2009
The $500,000 grant will develop companies’ platform technology, and will fund preclinical studies of its candidates for cardiovascular and cancer therapies.

MIP Enters into Agreement with Sanofi-Aventis for Development of a Selective Separation Polymer for Biopharmaceuticals
16 January 2009
The collaboration will develop molecularly imprinted polymers for the analysis of pharmacologically active peptides from plasma samples.

Apitope and Merck Serono Announce Licensing Agreement on Peptide Therapeutics for Multiple Sclerosis
14 January 2009
Under this agreement, Apitope has granted exclusive worldwide rights to Merck Serono to develop and commercialize Apitope’s product ATX-MS-1467.

New Experts Help New England Peptide Combat Global Acetonitrile Shortage
09 January 2009
Company has added globally-renowned experts in peptide research to develop cost-effective chemical solvent alternatives.